Skip to main content
Fig. 5 | BMC Immunology

Fig. 5

From: Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice

Fig. 5

Protection of the mice immunized with rTgADF against oral challenge. The mice were intranasally immunized with PBS or 30 μg of rTgADF. a Survival curves of the mice (n = 22) challenged with 4 × 104 tachyzoites (acute infection) and observed daily for mortality. b Abundance of tachyzoites was detected in the liver and brain of the mice (n = 8) after being challenged with 1 × 104 tachyzoites (chronic infection). Results are expressed as mean ± SD values. *, P < 0.05 compared to the PBS group

Back to article page